Male Infertility Clinical Trial
Official title:
Validation of New Devices Against Ambient Electromagnetic Radiation: A Randomized Double Blind Controlled Study
Project Summary Cell phones have become indispensable devices in the investigator's daily
life. These phones operate between 400 and 2000 MHz frequency bands and emit radiofrequency
electromagnetic waves (EMW). Radio-frequency electro-magnetic field exposure from cell phones
or other sources of microwaves have deleterious effects on sperm parameters (like sperm
count, morphology, motility). Further, EMW radiation emitted by mobile phones affects cells
and organelles, and results in disorientation of charged molecules within the cytosol and a
distortion of electron flow along the internal membranes of the cells. These cellular changes
results in the generation of ROS leading to oxidative stress, which in turn results in
radiation-induced sperm DNA fragmentation.
Radiation shield can help provide protection from high levels of EMW radiations deflecting,
diverting, and absorbing the radiation between the user and the source. A new EMW radiation
shield, Qi-Shield device developed by Waveguard GmbH (Bautzen, Germany) provides protection
against the radiations emitted by the smartphone and laptop devices. Qi-Shield utilizes
conductive fluids in a particular geometric arrangement intended to ameliorate the negative
effects of EMW radiation.
Study Aims:
To evaluate the changes in the semen parameters from the use of Qi-Shield device in sham
(control) and user groups To determine the molecular changes pertaining to sperm proteins
from the use of Qi-Shield device in sham (control) and user groups
Significance The negative health consequences of EMWs have been documented across a wide
range of device types, exposure frequencies and doses (Giuliani, 2010), at field strengths
substantially below the International Commission on Non-Ionizing Radiation Protection
(ICNIRP) guidelines for permissible exposures. In the absence of a revision in the ICNIRP
guidelines, near-term public exposures to EMWs will most certainly continue to increase,
despite the scientific evidence suggesting more careful review and recommendations to limit
exposure to electromagnetic fields as much as possible. At present, there is no veritable
means for counteracting the negative health consequences of human-made EMWs, revealing an
unmet need for a means of protecting from or ameliorating the negative effects of EMWs, and
the need for devising strategies for creating safer living and working environments in a time
of increasing EMW exposures.
Positive results in this study would demonstrate a means of counteracting negative effects on
human sperm due to EMWs. Documentation of protection due to the Qi-Shield devices would show
proof of principle that a low-cost passive device, portable and without battery or mains
power, can provide improvements in human sperm parameters, with promise for a means of
counteracting EMW-reduced fertility in large numbers of people. Confirmation of changes on
protein expression would provide data needed to identify specific pathways of action, insight
that is necessary for a more detailed understanding of the mechanisms of action of the EMW
protection effect. Taken together, these results would suggest further lines of study in EMW
protection, and provide clinical support for the adoption of EMW-protecting devices in the
home and workplace.
Status | Recruiting |
Enrollment | 40 |
Est. completion date | April 1, 2021 |
Est. primary completion date | March 1, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 50 Years |
Eligibility |
Inclusion Criteria: • Normal healthy men with normozoospermic semen parameters. Exclusion Criteria: - Subjects with a history of smoking - Chewing tobacco - Alcohol consumption - Antioxidant supplementation - Orchitis, varicocele, tuberculosis, diabetes mellitus, and hypertension - Viral/bacterial infection in the past 4 weeks - History of cardiac, neural, or nephrotic disease - Family history of any genetic disease |
Country | Name | City | State |
---|---|---|---|
United States | American Center for Reproductive Medicine, Cleveland Clinic | Cleveland | Ohio |
Lead Sponsor | Collaborator |
---|---|
Waveguard GmbH |
United States,
Agarwal A, Deepinder F, Sharma RK, Ranga G, Li J. Effect of cell phone usage on semen analysis in men attending infertility clinic: an observational study. Fertil Steril. 2008 Jan;89(1):124-8. Epub 2007 May 4. — View Citation
Agarwal A, Desai NR, Makker K, Varghese A, Mouradi R, Sabanegh E, Sharma R. Effects of radiofrequency electromagnetic waves (RF-EMW) from cellular phones on human ejaculated semen: an in vitro pilot study. Fertil Steril. 2009 Oct;92(4):1318-1325. doi: 10.1016/j.fertnstert.2008.08.022. Epub 2008 Sep 20. — View Citation
Agarwal A, Henkel R, Huang CC, Lee MS. Automation of human semen analysis using a novel artificial intelligence optical microscopic technology. Andrologia. 2019 Dec;51(11):e13440. doi: 10.1111/and.13440. Epub 2019 Oct 4. — View Citation
Desai NR, Kesari KK, Agarwal A. Pathophysiology of cell phone radiation: oxidative stress and carcinogenesis with focus on male reproductive system. Reprod Biol Endocrinol. 2009 Oct 22;7:114. doi: 10.1186/1477-7827-7-114. Review. — View Citation
Kesari KK, Agarwal A, Henkel R. Radiations and male fertility. Reprod Biol Endocrinol. 2018 Dec 9;16(1):118. doi: 10.1186/s12958-018-0431-1. Review. — View Citation
Kivrak EG, Yurt KK, Kaplan AA, Alkan I, Altun G. Effects of electromagnetic fields exposure on the antioxidant defense system. J Microsc Ultrastruct. 2017 Oct-Dec;5(4):167-176. doi: 10.1016/j.jmau.2017.07.003. Epub 2017 Aug 2. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sperm concentration | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Sperm concentration (millions/ mL) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 0 weeks | |
Primary | Sperm concentration | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Sperm concentration (millions/ mL) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 4 weeks | |
Primary | Sperm concentration | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Sperm concentration (millions/ mL) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 8 weeks | |
Primary | Total sperm motility | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Total motility (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 0 weeks | |
Primary | Total sperm motility | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Total motility (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 4 weeks | |
Primary | Total sperm motility | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Total motility (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 8 weeks | |
Primary | Progressive motility | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Progressive motility (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 0 weeks | |
Primary | Progressive motility | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Progressive motility (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 4 weeks | |
Primary | Progressive motility | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Progressive motility (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 8 weeks | |
Primary | Sperm morphology | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Sperm morphology (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 0 weeks | |
Primary | Sperm morphology | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Sperm morphology (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 4 weeks | |
Primary | Sperm morphology | Semen analysis will be carried out using LensHooke™X1 PRO semen quality analyzer. Sperm morphology (%) will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group). | 8 weeks | |
Primary | Seminal oxidative stress | ORP is considered as a marker of oxidative stress. Increased levels of oxidative stress is harmful to the spermatozoa. In semen samples ORP is measured using MiOXSYS analyzers. Seminal ORP will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group) to evaluate the change in the seminal oxidative stress due to use of Qi-shield. | 0 weeks | |
Primary | Seminal oxidative stress | ORP is considered as a marker of oxidative stress. Increased levels of oxidative stress is harmful to the spermatozoa. In semen samples ORP is measured using MiOXSYS analyzers. Seminal ORP will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group) to evaluate the change in the seminal oxidative stress due to use of Qi-shield. | 4 weeks | |
Primary | Seminal oxidative stress | ORP is considered as a marker of oxidative stress. Increased levels of oxidative stress is harmful to the spermatozoa. In semen samples ORP is measured using MiOXSYS analyzers. Seminal ORP will be assessed in both the groups (Qi-shield user group and sham Qi-shield user group) to evaluate the change in the seminal oxidative stress due to use of Qi-shield. | 8 weeks | |
Primary | Sperm DNA damage | Sperm DNA integrity is directly correlated with the quality of the spermatozoa. Increased levels of sperm DNA damage has negative impact on pregnancy and live birth rates. Sperm DNA fragmentation (SDF) is measured using TUNEL assay. In the current study levels of SDF before and after the use of Qi-shield will allow us to understand the effect of electromagnetic radiations on DNA integrity of spermatozoa. | 0 weeks | |
Primary | Sperm DNA damage | Sperm DNA integrity is directly correlated with the quality of the spermatozoa. Increased levels of sperm DNA damage has negative impact on pregnancy and live birth rates. Sperm DNA fragmentation (SDF) is measured using TUNEL assay. In the current study levels of SDF before and after the use of Qi-shield will allow us to understand the effect of electromagnetic radiations on DNA integrity of spermatozoa. | 4 weeks | |
Primary | Sperm DNA damage | Sperm DNA integrity is directly correlated with the quality of the spermatozoa. Increased levels of sperm DNA damage has negative impact on pregnancy and live birth rates. Sperm DNA fragmentation (SDF) is measured using TUNEL assay. In the current study levels of SDF before and after the use of Qi-shield will allow us to understand the effect of electromagnetic radiations on DNA integrity of spermatozoa. | 8 weeks | |
Primary | Sperm proteome | In spermatozoa normal expression of fertility associated proteins are essential for fertilization process. Several studies reported that aberrant expression of proteins related to sperm function as capacitation, hyperactivation, acrosome reaction and binging of zona pellucida with ovum in infertile men. Furthermore, electromagnetic radiations can also cause molecular changes. In the present study, proteome profile of the spermatozoa from subjects before and after the use of Qi-shield will provide the information related to the molecular changes at protein level. | 0 weeks | |
Primary | Sperm proteome | In spermatozoa normal expression of fertility associated proteins are essential for fertilization process. Several studies reported that aberrant expression of proteins related to sperm function as capacitation, hyperactivation, acrosome reaction and binging of zona pellucida with ovum in infertile men. Furthermore, electromagnetic radiations can also cause molecular changes. In the present study, proteome profile of the spermatozoa from subjects before and after the use of Qi-shield will provide the information related to the molecular changes at protein level. | 4 weeks | |
Primary | Sperm proteome | In spermatozoa normal expression of fertility associated proteins are essential for fertilization process. Several studies reported that aberrant expression of proteins related to sperm function as capacitation, hyperactivation, acrosome reaction and binging of zona pellucida with ovum in infertile men. Furthermore, electromagnetic radiations can also cause molecular changes. In the present study, proteome profile of the spermatozoa from subjects before and after the use of Qi-shield will provide the information related to the molecular changes at protein level. | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05503862 -
Home Semen Testing in Men Beginning Attempts to Conceive
|
N/A | |
Recruiting |
NCT03307655 -
Relationship Between Nitric Oxide (NO) in Follicular Fluid and Sperm Fertilization Ability
|
N/A | |
Withdrawn |
NCT02839447 -
A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0
|
||
Completed |
NCT00975117 -
Spermotrend in the Treatment of Male Infertility
|
Phase 3 | |
Completed |
NCT00756561 -
HOP-2A - Intratesticular Hormone Levels
|
N/A | |
Completed |
NCT02889341 -
Valuation of Variable Dose of Docosahexanoic Acid for the Improvement of the Parameters of Male Fertility
|
N/A | |
Not yet recruiting |
NCT03167008 -
Vitamin D Level vs Semen Parameters
|
||
Completed |
NCT02268123 -
Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation
|
||
Completed |
NCT01232465 -
Impact of Sperm DNA Integrity on In Vitro Cycles
|
N/A | |
Recruiting |
NCT00119925 -
'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
|
N/A | |
Completed |
NCT03552081 -
Tobacco and Sperm Genome: Effects of Smoking Cessation
|
N/A | |
Recruiting |
NCT05200663 -
Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility
|
Phase 2 | |
Completed |
NCT02025270 -
MSCs For Treatment of Azoospermic Patients
|
Phase 1/Phase 2 | |
Recruiting |
NCT06147700 -
Identifying Molecular Determinants of Infertility in Men (MODIFY)
|
||
Recruiting |
NCT06188936 -
Home Semen Analysis Tests as a Screening Tool for Fertility Patients
|
N/A | |
Recruiting |
NCT04200118 -
Epigenetic and Genetic Effects in Cancer Patients: Analysis Pre and After Treatment
|
||
Terminated |
NCT02605070 -
Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia
|
Phase 3 | |
Completed |
NCT01407432 -
Impact of Folates in the Care of the Male Infertility
|
Phase 3 | |
Completed |
NCT00596739 -
A Study of the Pre- and Post-operative Semen Analyses and Reproductive Hormone Levels of Men Undergoing Weight-reduction Surgery
|
N/A | |
Completed |
NCT00315029 -
Patient-Centered Implementation Trial for Single Embryo Transfer
|
N/A |